South Korea · Delayed Price · Currency is KRW SCL Science Company Description
SCL Science Inc. produces medical hemostatic agents using biomimetic technology.
Its products includes BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal which is used for the specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasis and sealing products; STOP, a non-bleeding intravascular injection; Film that prevents leakage at intestinal and vascular anastomosis sites; and InnoLOCK and InTro, a vascular interventional procedure items, as well as operates bio-logistics business.
The company also engages in conducting clinical trial analysis services related to new drug development, in vitro diagnostic medical device performance evaluation, transportation of pharmaceuticals and clinical trial samples, etc. The company was formerly known as InnoTherapy, Inc. and changed its name to SCL Science Inc. in March 2024.
SCL Science Inc. was founded in 2010 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 2010 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 62 |
| CEO | Moon Lee |
Contact Details
Address: #1206~1210, Ace High Tech City 2-complex Seoul, 07282 South Korea | |
| Phone | 82 2 6959 1338 |
| Website | innotherapy.com |
Stock Details
| Ticker Symbol | 246960 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Moon Lee | Chief Executive Officer |
| In Moon | Chief Operating Officer |